Bharat Immunologicals & Biologicals Corporation Ltd Q1 Results

  • BSE: 524663
  • NSE: -
  • ISIN: INE994B01014
  • Sector: Biotechnology & Drugs
BSE
170.18 (1.07%)
Volume262.00
Updated: Fri 17 Jul, 2026 | 09:31:26
NSE
This stock is not traded on NSE
Today: 16.76
17.10
52-Wk: 14.10
23.90

Q1 Results Highlights

Quarter ended Jun 23

    Note: Comparison is on QoQ basis

    Quarterly - Bharat Immunologicals & Biologicals Corporation Ltd Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 23Mar 23QoQ Comp
    Total Operating Expense 4.3514.10-69.16%
    Depreciation/ Amortization 0.030.04-5.77%
    Operating Income -4.35-6.45-32.55%
    Net Income -4.59-4.296.85%
    Net Income Before Taxes -5.97-6.26-4.66%
    Other Operating Expenses Total 0.422.90-85.65%
    Total Revenue 0.007.650.00%
    Diluted Normalized EPS -1.06-0.996.61%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market